Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety
- Conditions
- Neuromuscular Blocking AgentsSurgery--ComplicationsNeuromuscular BlockadeAnestheticsRocuroniumAnesthesia Complication
- Interventions
- Other: Deep neuromuscular block
- Registration Number
- NCT04124757
- Lead Sponsor
- Leiden University Medical Center
- Brief Summary
Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal intubation and to improve surgical working conditions. Several investigations have shown that a deep neuromuscular block (NMB) improves the surgical working conditions over a moderate NMB and effectively precludes sudden deterioration of the surgical field. However, whether the improvement of surgical working conditions translates into less intra- and postoperative complications remains uncertain. Small prospective or retrospective studies shown an decrease of the incidence of intraoperative adverse events and postoperative complications after a deep NMB. There is a need to confirm these outcome data prospectively, in a large number of patients and clinics and during a variety of surgical procedures.
- Detailed Description
Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal intubation and to improve surgical working conditions. Several investigations have shown that a deep neuromuscular block (NMB) (post tetanic count (PTC) 1-2 twitches) improves the surgical working conditions over a moderate NMB (TOF count 1-3 twitches) and effectively precludes sudden deterioration of the surgical field. However, whether the improvement of surgical working conditions translates into less intra- and postoperative complications remains uncertain. A recent retrospective analysis of neuromuscular management during laparoscopic retroperitoneal surgery showed a reduced rate of unplanned 30 day readmissions when a deep NMB over a moderate NMB was applied (3.8% vs. 12.7%).In addition, a pooled analysis of 4 randomized controlled trials comparing different levels of intra-abdominal pressure and neuromuscular blockade during laparoscopic donor nephrectomy, showed a significant reduction in the incidence of intra-operative surgical complications from 12.6% with moderate NMB to 4.8% with deep NMB.
These previous observations were made in small prospective or retrospective studies. There is a need to confirm these outcome data prospectively, in a larger prospective trial for a variety of surgical procedures. We therefore propose a multi-center, randomized controlled trial, to study the effect of a deep NMB (PTC 1-2 twitches) versus standard NMB (single induction dose rocuronium) in a variety of laparoscopic surgical procedures on the incidence of intraoperative adverse events and postoperative outcome data.
In this study the effect of deep neuromuscular block compared to standard neuromuscular block on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system is evaluated.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 731
- Patients scheduled for elective laparoscopic procedure with a complexity according to the BUPA classification for case complexity: 'MAJOR', 'MAJOR Plus or 'COMPLEX MAJOR'
- ASA (merican society of anesthesiologists) class I-III
- > 18 years of age
- Ability to give oral and written informed consent
- Low or intermediate complexity laparoscopic procedures (BUPA 'SIMPLE' or 'INTER')
- Known or suspected neuromuscular disorders impairing neuromuscular function
- Allergies to muscle relaxants, anesthetics or narcotics mentioned in paragraph 5.2
- A (family) history of malignant hyperthermia
- Women who are or may be pregnant or are currently breast feeding
- Chronic use of any type of opioid or psychotropic drug
- Use of NSAID's shorter than 5 days before surgery
- Indication for rapid sequence induction
- Contra-indication for sugammadex use (e.g. known sugammadex allergy or Glomerular Filtration Rate <30 ml/min)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Deep neuromuscular block Deep neuromuscular block Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count
- Primary Outcome Measures
Name Time Method Classic score Day of surgery The incidence of symptomatic intra-operative adverse events requiring intervention or treatment (ClassIntra®grade ≥ 2) during laparoscopic surgery in the standard of care versus the deep NMB group, as scored by the attending surgeon and anesthesiologist at the end of every procedure. A recent update of the ClassIntra®grade also involved intraoperative adverse events related to anesthesia \[Gawria et al 2023\]. This study will use both the original classic scoring, as well as an adapted version of the updated classic scoring system.
The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).
- Secondary Outcome Measures
Name Time Method L-SRS (Leiden Surgical Rating Scale) Day of surgery To study the effect of deep neuromuscular block compared to standard neuromuscular block on peroperative surgical working conditions following the Leiden Surgical Rating scale (a 5 point scale, ranging from poor (1) to excellent (5) surgical conditions.
Quality of recovery (QoR) 2 postoperative days To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of Recovery at post-operative day 1, 2 according to the Quality of Recovery-40
Quality of life (QoL) 30 postoperative days To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of life at post-operative day 30 Short Form-36
30 day post-operative complications 30 postoperative days To study the effect of deep neuromuscular block compared to standard neuromuscular block on 30 day post-operative complications according the Clavien-Dindo score en Comprehensive Complication Index and unplanned readmissions
Trial Locations
- Locations (8)
Université De Lorraine
🇫🇷Nancy, Meurthe-et-Moselle, France
Istituto Nazionale Dei Tumori
🇮🇹Milano, Italy
RadboudUMC
🇳🇱Nijmegen, Gelderland, Netherlands
LUMC
🇳🇱Leiden, Zuid-Holland, Netherlands
Noordwest ziekenhuis groep
🇳🇱Alkmaar, Netherlands
Netherlands Cancer institute
🇳🇱Amsterdam, Netherlands
Canisius Wilhelmina Ziekenhuis
🇳🇱Nijmegen, Netherlands
Hospital Universitari I Politecnic La Fe
🇪🇸Valencia, Spain